|3Sep 16, 6:07 PM ET

Deep Track Special Opportunities Fund, LP 3

3 · LB PHARMACEUTICALS INC · Filed Sep 16, 2025

Insider Transaction Report

Form 3
Period: 2025-09-12
Holdings
  • Common Stock

    666,666
Footnotes (1)
  • [F1]Represents securities held by Deep Track Special Opportunities Fund, LP. Deep Track Capital, LP is the investment manager of Deep Track Special Opportunities Fund, LP. Mr. David Kroin is the managing member of Deep Track Capital GP, LLC, the general partner of Deep Track Capital, LP., and by virtue of such status may be deemed to be the beneficial owner of the shares owned by Deep Track Special Opportunities Fund, LP. Affiliates of the Reporting Person, including Deep Track Biotechnology Master Fund, Ltd, Deep Track Capital, LP and Mr. Kroin, have separately filed Section 16 reports with respect to the shares of Issuer common stock they may be deemed to beneficially own.

Documents

1 file
  • 3
    form3-09162025_100901.xmlPrimary